Literature DB >> 23436405

siRNA design principles and off-target effects.

Sebastian Petri1, Gunter Meister.   

Abstract

Short interfering RNAs (siRNAs) are a major research tool that allows for knock-down of target genes via selective mRNA destruction in almost all eukaryotic organisms. siRNAs typically consist of a synthetic ∼21 nucleotide (nt) RNA-duplex where one strand is designed with perfect complementarity to the target mRNA. Although siRNAs were initially thought to be very target-specific because of their design, it turned out during the last years that all siRNAs have a more or less pronounced intrinsic off-target activity which can make the interpretation of data from siRNA experiments difficult. Here we describe essential rules for siRNA design that should be taken into account in order to obtain potent siRNAs with minimal off-target activity. In addition, we describe how to control for off-target activity in siRNA experiments.

Mesh:

Substances:

Year:  2013        PMID: 23436405     DOI: 10.1007/978-1-62703-311-4_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  Growth-restricting effects of siRNA transfections: a largely deterministic combination of off-target binding and hybridization-independent competition.

Authors:  Neha Daga; Simone Eicher; Abhilash Kannan; Alain Casanova; Shyan H Low; Saskia Kreibich; Daniel Andritschke; Mario Emmenlauer; Jeremy L Jenkins; Wolf-Dietrich Hardt; Urs F Greber; Christoph Dehio; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2018-10-12       Impact factor: 16.971

2.  Involvement of Rho-associated coiled-coil kinase signaling inhibition in TGF-β1/Smad2, 3 signal transduction in vitro.

Authors:  Zhao-Hui Feng; Xiao-Hui Zhang; Jia-Qi Zhao; Jun-Ze Ma
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

3.  Identification of DISE-inducing shRNAs by monitoring cellular responses.

Authors:  Monal Patel; Marcus E Peter
Journal:  Cell Cycle       Date:  2018-04-03       Impact factor: 4.534

4.  Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism.

Authors:  William Putzbach; Quan Q Gao; Monal Patel; Stijn van Dongen; Ashley Haluck-Kangas; Aishe A Sarshad; Elizabeth T Bartom; Kwang-Youn A Kim; Denise M Scholtens; Markus Hafner; Jonathan C Zhao; Andrea E Murmann; Marcus E Peter
Journal:  Elife       Date:  2017-10-24       Impact factor: 8.140

Review 5.  Non-viral nanocarriers for siRNA delivery in breast cancer.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  J Control Release       Date:  2014-05-27       Impact factor: 9.776

Review 6.  DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells.

Authors:  William Putzbach; Quan Q Gao; Monal Patel; Ashley Haluck-Kangas; Andrea E Murmann; Marcus E Peter
Journal:  Trends Cancer       Date:  2018-01-08

Review 7.  RNA-based therapeutics for colorectal cancer: Updates and future directions.

Authors:  Jingwen Liu; Bin Guo
Journal:  Pharmacol Res       Date:  2019-12-19       Impact factor: 7.658

8.  Effective inhibition of different Japanese encephalitis virus genotypes by RNA interference targeting two conserved viral gene sequences in vitro and in vivo.

Authors:  Lei Yuan; Xiaojuan Feng; Xuelian Gao; Yu Luo; Chaoyue Liu; Peng Liu; Guolin Yang; Hong Ren; Rong Huang; Yalan Feng; Jian Yang
Journal:  Virus Genes       Date:  2018-09-18       Impact factor: 2.332

9.  Engineering Duplex RNAs for Challenging Targets: Recognition of GGGGCC/CCCCGG Repeats at the ALS/FTD C9orf72 Locus.

Authors:  Jiaxin Hu; Jing Liu; Liande Li; Keith T Gagnon; David R Corey
Journal:  Chem Biol       Date:  2015-11-12

Review 10.  Gene therapy for ALS: A review.

Authors:  Defne A Amado; Beverly L Davidson
Journal:  Mol Ther       Date:  2021-04-09       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.